Decreased Circulating Myeloid-Derived Suppressor Cells (MDSCs) at First Follow-up Predict Favorable Response to Immunotherapy in a Randomized Trial of Nivolumab and Bevacizumab in Recurrent GBM

Manmeet Ahluwalia

Decreased Circulating Myeloid-Derived Suppressor Cells (MDSCs) at First Follow-up Predict Favorable Response to Immunotherapy in a Randomized Trial of Nivolumab and Bevacizumab in Recurrent GBM

Manmeet Ahluwalia

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - 2019
Event	Congress of Neurological Surgeons 2019 Annual Meeting - Duration: Jan 1 2019 → …

Conference

Conference	Congress of Neurological Surgeons 2019 Annual Meeting
Period	1/1/19 → …

Disciplines

Medicine and Health Sciences

Cite this

@conference{ba7a56be871a46da971113ccfd7c6472,

title = "Decreased Circulating Myeloid-Derived Suppressor Cells (MDSCs) at First Follow-up Predict Favorable Response to Immunotherapy in a Randomized Trial of Nivolumab and Bevacizumab in Recurrent GBM",

author = "Manmeet Ahluwalia",

year = "2019",

language = "American English",

note = "Congress of Neurological Surgeons 2019 Annual Meeting ; Conference date: 01-01-2019",

}